| PERIOD ENDING | 30-Nov-08 | 30-Nov-07 | 30-Nov-06 | | Total Revenue | 4,575,417 | 10,186,781 | 16,266,662 | | Cost of Revenue | 5,085,231 | 12,639,486 | 15,171,384 | | | Gross Profit | (509,814) | (2,452,705) | 1,095,278 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 129,752 | 173,202 | 193,307 | | Non Recurring |
-
| 14,319 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (639,566) | (2,640,226) | 901,971 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (76,029) | 66,629 | | Earnings Before Interest And Taxes | (561,528) | (3,081,081) | 942,649 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (561,528) | (3,081,081) | 942,649 | | Income Tax Expense | 547,557 | (1,140,000) | 348,780 | | Minority Interest | 4,097 | (1,927) | (13,415) | | | | Net Income From Continuing Ops | (1,109,085) | (1,941,081) | 593,869 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,109,085) | (1,941,081) | 593,869 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,109,085) | ($1,941,081) | $593,869 |
|
1.48% Nasdaq 
Income Statement
